Here is an analysis of Fagron using the methodology of Benjamin Graham, the father of value investing as explained by John Reese and Jack Forehand in The Guru Investor.
I don't know much about the company except that it is literally a compounder (it mixes drugs: https://en.wikipedia.org/wiki/Compounding )
SECTOR: [PASS] FAGRON is in the pharmaceutical sector, which this methodology accepts. Technology and financial stocks were considered too risky to invest in when this methodology was published.
SALES: [PASS] The investor must select companies of "adequate size". This includes companies with annual sales greater than $340 million. FAGRON's 2017 sales of 437 million passes this test.
CURRENT RATIO: [FAIL] The current ratio must be greater than or equal to 2. Companies that meet this criterion are typically financially secure and defensive. The current assets are €36 million ? and current liabilities are €25 million? FAGRON's current ratio of 1.4 fails the test.
LONG-TERM DEBT IN RELATION TO NET CURRENT ASSETS: [FAIL] For industrial companies, long-term debt must not exceed net current assets (current assets minus current liabilities). Companies that meet this criterion display one of the attributes of a financially secure organization. The long-term debt for FAGRON is €236 million, while the net current assets are €11 million. FAGRON fails this test.
LONG-TERM EPS GROWTH: [FAIL] Companies must increase their EPS by at least 30% over a ten-year period and EPS must not have been negative for any year within the last 5 years. Companies with this type of growth tend to be financially secure and have proven themselves over time. FAGRON made losses in recent years and fails this test.
Earnings Yield: [FAIL] The Earnings/Price (E/P) ratio, based on the lower of the current E/P or the E/P using average earnings over the last 3 fiscal years, must be "moderate", which this methodology states is greater than 7%. Stocks with high E/Ps are more defensive by nature. FAGRON's E/P at the moment is only 5% and fails this test.
GRAHAM NUMBER VALUE: [FAIL] The Price/Book ratio must also be reasonable. That is the Graham number value must be greater than the market price. FAGRON has a Graham number of √(15 x €0,65 EPS x 1,5 x €2,7 Book Value) = €6,4
See www.beterinbeleggen.nl for analysis of quality companies.